Hetero gets DGCI approval for generic version of tocilizumab for treatment of Covid-19

"The Drug Controller General of India (DCGI) has issued for restricted use, Emergency Use Authorisation (EUA) for the generic version of Tocilizumab," it said in a statement. India has faced a huge shortage of tocilizumab, used to treat critically ill Covid patients-during the Covid surge.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news